Daily Progress: Cohen & Steers Inc (CNS) Drop -3.12%, Closing at $66.21

Nora Barnes

Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.

In the latest session, Cohen & Steers Inc (NYSE: CNS) closed at $66.21 down -3.12% from its previous closing price of $68.34. In other words, the price has decreased by -$3.12 from its previous closing price. On the day, 0.85 million shares were traded. CNS stock price reached its highest trading level at $69.6399 during the session, while it also had its lowest trading level at $66.02.

Ratios:

For a deeper understanding of Cohen & Steers Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 34.44 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 15.16. For the most recent quarter (mrq), Quick Ratio is recorded 4.61 and its Current Ratio is at 4.61. In the meantime, Its Debt-to-Equity ratio is 0.25 whereas as Long-Term Debt/Eq ratio is at 0.25.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, BofA Securities on June 30, 2025, initiated with a Underperform rating and assigned the stock a target price of $67.

On October 17, 2024, UBS Upgraded its rating to Neutral which previously was Sell and also upped its target price recommendation from $63 to $102.

On January 05, 2024, UBS started tracking the stock assigning a Sell rating and target price of $68.UBS initiated its Sell rating on January 05, 2024, with a $68 target price.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 04 ’25 when STEERS ROBERT HAMILTON bought 42,909 shares for $67.96 per share. The transaction valued at 2,916,099 led to the insider holds 7,109,168 shares of the business.

STEERS ROBERT HAMILTON bought 38,650 shares of CNS for $2,635,839 on Nov 03 ’25. The Executive Chairman now owns 7,081,234 shares after completing the transaction at $68.20 per share. On Nov 05 ’25, another insider, STEERS ROBERT HAMILTON, who serves as the Executive Chairman of the company, bought 19,329 shares for $67.61 each. As a result, the insider paid 1,306,834 and bolstered with 7,128,497 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CNS now has a Market Capitalization of 3377209088 and an Enterprise Value of 3250775296. As of this moment, Cohen’s Price-to-Earnings (P/E) ratio for their current fiscal year is 20.79, and their Forward P/E ratio for the next fiscal year is 19.03. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.32. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.10 while its Price-to-Book (P/B) ratio in mrq is 6.14. Its current Enterprise Value per Revenue stands at 5.888 whereas that against EBITDA is 16.394.

Stock Price History:

The Beta on a monthly basis for CNS is 1.27, which has changed by -0.32148528 over the last 52 weeks, in comparison to a change of 0.15085125 over the same period for the S&P500. Over the past 52 weeks, CNS has reached a high of $107.31, while it has fallen to a 52-week low of $64.29. The 50-Day Moving Average of the stock is -3.25%, while the 200-Day Moving Average is calculated to be -12.72%.

Shares Statistics:

For the past three months, CNS has traded an average of 291.76K shares per day and 355080 over the past ten days. A total of 51.00M shares are outstanding, with a floating share count of 27.27M. Insiders hold about 46.53% of the company’s shares, while institutions hold 58.70% stake in the company. Shares short for CNS as of 1761868800 were 1753239 with a Short Ratio of 6.01, compared to 1759190400 on 2047677. Therefore, it implies a Short% of Shares Outstanding of 1753239 and a Short% of Float of 6.280000500000001.

Dividends & Splits

According to the company, the forward annual dividend rate for CNS is 2.48, from 2.45 in the trailing year. Against a Trailing Annual Dividend Yield of 0.035850164. The stock’s 5-year Average Dividend Yield is 2.88.

Earnings Estimates

Its stock is currently analyzed by 2.0 different market analysts. The consensus estimate for the next quarter is $0.82, with high estimates of $0.83 and low estimates of $0.81.

Analysts are recommending an EPS of between $3.12 and $2.89 for the fiscal current year, implying an average EPS of $3.03. EPS for the following year is $3.43, with 3.0 analysts recommending between $3.51 and $3.33.

Revenue Estimates

A total of 2 analysts believe the company’s revenue will be $144.41M this quarter.It ranges from a high estimate of $145.59M to a low estimate of $143.22M. As of. The current estimate, Cohen & Steers Inc’s year-ago sales were $139.78MFor the next quarter, 2 analysts are estimating revenue of $146.57M. There is a high estimate of $147.25M for the next quarter, whereas the lowest estimate is $145.89M.

A total of 2 analysts have provided revenue estimates for CNS’s current fiscal year. The highest revenue estimate was $555.71M, while the lowest revenue estimate was $553.53M, resulting in an average revenue estimate of $554.62M. In the same quarter a year ago, actual revenue was $517.42MBased on 2 analysts’ estimates, the company’s revenue will be $613.12M in the next fiscal year. The high estimate is $624.09M and the low estimate is $602.15M.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.